TIMP2 and ganglioneuroma: Moreover, in the β-blockers (−) group, the occurrence of GN was associated with a decrease in TIMP-2 levels [84.75 (65.5–108.0) ng/mL vs. 121.0 (94.0–131.0 ng/mL, p = 0.029)].